Global Pharma Companies Must Nurture ‘Intercultural Intelligence’
Insights From Jesse Sibarium, SVP, General Manager At PTC Therapeutics
Equality, Diversity and Inclusion (ED&I) carries huge potential for business and society. However, various events around the globe, including the Black Lives Matter movement, highlighted that there are unaddressed challenges which need to be tackled. PTC Therapeutics, a global biopharmaceutical company with presence in in Europe, Middle East and Africa (EMEA) has initiated a new ED&I program to further strengthen its values and encourage positive progress globally.
• Source: Shutterstock
PTC Therapeutics, Inc. has been operating across more than 20 EMEA countries, arguably one of the most culturally diverse regions with over 2,000 languages spoken and every world religion represented, for nearly 10 years.
About the Author
Jesse Sibarium is senior vice president, general manager for Central Eastern Europe, Commonwealth of Independent States, Middle East and Africa at PTC Therapeutics.
PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of medicines that provide benefits to patients with rare disorders.
